- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00705302
Patient Education in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Effect and Costs
February 10, 2017 updated by: Norwegian University of Science and Technology
A Randomised Controlled Trial of the Effect of a Patient Education Program for Patients With Chronic Obstructive Pulmonary Disease (COPD)
The aim of this study is to determine the long term effect of a self-help group in a patient education program for patients with chronic obstructive pulmonary disease (COPD).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Pulmonary rehabilitation is aimed to increase the level of health of patients with COPD by increasing their self care ability.
A recent updated systematic review concluded that evidence strongly supports respiratory rehabilitation as part of the spectrum of management of patients with chronic obstructive pulmonary disease (COPD).
Studies of pulmonary rehabilitation programs lasting up to 18 months show that effects are mainly maintained throughout the duration of the program.
The long term effect, however, is mostly studied for programs of shorter durations.
Some of the studies with shorter duration have found that the achieved benefit was lost or diminished during the follow up period, while others have found that the effect has been maintained up to 18 months.
Our necessity in the rehabilitative field is to find strategies to maintain benefits during time.
Study Type
Interventional
Enrollment (Actual)
88
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Trondheim, Norway, N-7491
- Department of Public Health and General Practice, Norwegian University of Science and Technology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- (FEV1) lower that 75% of predicted
- the ability to participate in physical activity
- not been hospitalized the last month.
Exclusion Criteria:
- contraindications for physical activity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: patient education including self-help
Patients in the arm will participate in a three months patient education and exercise program including a self-help group in 3 months of time.
|
Combined educational and exercise program for pulmonary rehabilitation, with (1) or without(2 a self-help group.
The educational part consists firstly of two days with group meetings with information from medical doctor, pharmacist, psychologist, ergonomist, nurse, social worker, physiotherapist and a clinical nutritional physiologist.
One more day will be held after 3 months and it is the participants themselves who decide on the content of these days.
An experienced patient will participate throughout the course.
The exercise part consists of group training twice a week for 3 months with 10-15 participants in each group.
Patients will instead of five of the group training sessions, participate in a self-help group.
|
|
Active Comparator: patient education
Patients in arm 2 will participate in the same patient education and exercise program as arm 1, but without an additional self-help group.
|
Combined educational and exercise program for pulmonary rehabilitation.
The educational part consists firstly of two days with group meetings with information from medical doctor, pharmacist, psychologist, ergonomist, nurse, social worker, physiotherapist and a clinical nutritional physiologist.
One more day will be held after 3 months and it is the participants themselves who decide on the content of these days.
An experienced patient will participate throughout the course.
The exercise part consists of group training twice a week for 3 months with 10-15 participants in each group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
St. George's Respiratory Questionnaire (SGRQ) - Total score
Time Frame: Baseline, 3, 6 and 12 months
|
Baseline, 3, 6 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Modified Borg scale (MBS) pre, during and post 6MWT
Time Frame: Baseline, 3, 6 and 12 months
|
Baseline, 3, 6 and 12 months
|
|
Patient Activation Measure (PAM)
Time Frame: Baseline, 3, 6 and 12 months
|
Baseline, 3, 6 and 12 months
|
|
The Perceived Quality of Life Scale
Time Frame: Baseline, 3, 6 and 12 months
|
Baseline, 3, 6 and 12 months
|
|
6 minute walk test (6MWT)
Time Frame: Baseline, 3, 6 and 12 months
|
Baseline, 3, 6 and 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Aslak Steinsbekk, PhD, Norwegian University of Technology and Science
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Lomundal BK, Steinsbekk A. Observational studies of a one year self-management program and a two year pulmonary rehabilitation program in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2007;2(4):617-24.
- Lomundal BK, Steinsbekk A. Five-year follow-up of a one-year self-management program for patients with COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:87-93. doi: 10.2147/COPD.S27352. Epub 2012 Feb 9.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2007
Primary Completion (Actual)
August 1, 2011
Study Completion (Actual)
November 1, 2011
Study Registration Dates
First Submitted
June 24, 2008
First Submitted That Met QC Criteria
June 25, 2008
First Posted (Estimate)
June 26, 2008
Study Record Updates
Last Update Posted (Actual)
February 13, 2017
Last Update Submitted That Met QC Criteria
February 10, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10307300
- 17732 (Other Identifier: NSD)
- 4.2007.2589 (Other Identifier: REK)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD)
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
University College, LondonUniversity of Cambridge; National Institute for Health Research, United Kingdom and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Virginia Commonwealth UniversityFisher and Paykel HealthcareCompletedChronic Obstructive Pulmonary Disease(COPD)United States
-
Morair Medtech, LLCRecruitingEmphysema | COPD | Emphysema or COPD | COPD (Chronic Obstructive Pulmonary Disease) | Emphysema, PulmonaryAustria, Germany, Netherlands
-
Reham Mohammed ElmorshedyCompletedChronic Obstructive Pulmonary Disease(COPD)Egypt
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Medtronic BRCUnknownCOPD | COPD Exacerbation
-
Beaumont HospitalAerogenCompletedChronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | Copd Exacerbation AcuteIreland
-
Chiesi Farmaceutici S.p.A.CompletedModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
-
Barron Associates, Inc.National Heart, Lung, and Blood Institute (NHLBI); University of VirginiaNot yet recruitingCOPD | COPD - Chronic Obstructive Pulmonary DiseaseUnited States
Clinical Trials on Group training with self-help group
-
University of MiamiActive, not recruiting
-
Virginia Commonwealth UniversityCompletedDisordered Eating BehaviorsUnited States
-
The University of Hong KongRecruiting
-
Ottawa Hospital Research InstituteOntario Mental Health FoundationUnknownBinge Eating DisorderCanada
-
The Hong Kong Polytechnic UniversityCompletedConstipationHong Kong
-
Université Libre de BruxellesJules Bordet Institute; Centre de Psycho-Oncologie (CPO); Hôpital Universitaire...RecruitingMyeloma Multiple | Metastatic CancersBelgium
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompleted
-
Technical University of MunichGerman Center for Vertigo and Balance DisordersUnknownSomatoform Vertigo/Dizziness
-
National Institute of Neurological Disorders and...Completed
-
Finnish Institute of Occupational HealthCity of Helsinki; Finnish Work Environment Fund; NordForsk; City of Turku, Occupational... and other collaboratorsUnknownChronic Insomnia | Sleep Disorders, Circadian Rhythm | Cognitive Behavioral Therapy | Sleep Disorders, Shift-WorkFinland